Biogen, Astra AB, Schering-Plough S.A. deal

BGEN entered into exclusive marketing agreements for its interferon beta-1a treatment for relapsing forms of multiple sclerosis. Astra received exclusive rights to the product in Denmark, Finland, Ice...